• Leif Ryd
    Medical Management Centre, LIME, Karolinska Institute, Stockholm, Sweden
  • Mats Brittberg
    Cartilage Research Unit, University of Gothenburg. Department of Orthopaedics, Kungsbacka Hospital, Kungsbacka, Sweden
  • Karl Eriksson
    Department of Orthopedics, Southern Hospital, Stockholm, Sweden
  • Jukka S. Jurvelin
    Faculty of Science and Forestry, University of Eastern Finland, Kuopio, Finland
  • Anders Lindahl
    Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
  • Stefan Marlovits
    Medical University of Vienna, Vienna, Austria
  • Per Möller
    Episurf Medical, Stockholm, Sweden
  • James B. Richardson
    Keele University, RJAH, Oswestry, UK
  • Matthias Steinwachs
    Sport Clinic Zürich, Klinik Hirslanden, Zürich, Switzerland
  • Marcy Zenobi-Wong
    Cartilage Engineering + Regeneration Laboratory, Zürich, Switzerland

書誌事項

タイトル別名
  • Definition and Diagnosis of an Elusive Clinical Entity

説明

<jats:sec><jats:title>Objective</jats:title><jats:p> An attempt to define pre-osteoarthritis (OA) versus early OA and definitive osteoarthritis. </jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p> A group of specialists in the field of cartilage science and treatment was formed to consider the nature of OA onset and its possible diagnosis. </jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p> Late-stage OA, necessitating total joint replacement, is the end stage of a biological process, with many previous earlier stages. Early-stage OA has been defined and involves structural changes identified by arthroscopy or radiography. The group argued that before the “early-stage OA” there must exist a stage where cellular processes, due to the presence of risk factors, have kicked into action but have not yet resulted in structural changes. The group suggested that this stage could be called “pre-osteoarthritis” (pre-OA). </jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p> The group suggests that defining points of initiation for OA in the knee could be defined, for example, by traumatic episodes or surgical meniscectomy. Such events may set in motion metabolic processes that could be diagnosed by modern MRI protocols or arthroscopy including probing techniques before structural changes of early OA have developed. Preventive measures should preferably be applied at this pre-OA stage in order to stop the projected OA “epidemic.” </jats:p></jats:sec>

収録刊行物

  • CARTILAGE

    CARTILAGE 6 (3), 156-165, 2015-05-13

    SAGE Publications

被引用文献 (1)*注記

もっと見る

問題の指摘

ページトップへ